Detection potential to point-like neutrino sources with the NEMO-km3 telescope

The NEMO Collaboration is conducting an R&D activity towards the construction of a Mediterranean km3 neutrino telescope. In this work, we present the results of Monte Carlo simulation studies on the capability of the proposed NEMO telescope to detect and identify point-like sources of high energy muon neutrinos.Comment: To be published on BCN06 proceedings (Barcelona, July 4-7, 2006

Novel compounds targeting the RNA-binding protein HuR : Structure-based design, synthesis and interaction studies

The key role of RNA-binding proteins (RBPs) in regulating post-transcriptional processes and their involvement in several pathologies (i.e., cancer and neurodegeneration) have highlighted their potential as therapeutic targets. In this scenario, Embryonic Lethal Abnormal Vision (ELAV) or Hu proteins and their complexes with target mRNAs have been gaining growing attention. Compounds able to modulate the complex stability could constitute an innovative pharmacological strategy for the treatment of numerous diseases. Nevertheless, medicinal-chemistry efforts aimed at developing such compounds are still at an early stage. As part of our ongoing research in this field, we hereby present the rational design and synthesis of structurally novel HuR ligands, potentially acting as HuR-RNA interferers. The following assessment of the structural features of their interaction with HuR, combining saturation-transfer difference NMR and in silico studies, provides a guide for further research on the development of new effective interfering compounds of the HuR-RNA complex

Exploration of ligand binding modes towards the identification of compounds targeting HuR: a combined STD-NMR and Molecular Modelling approach

Post-transcriptional processes have been recognised as pivotal in the control of gene expression, and impairments in RNA processing are reported in several pathologies (i.e., cancer and neurodegeneration). Focusing on RNA-binding proteins (RBPs), the involvement of Embryonic Lethal Abnormal Vision (ELAV) or Hu proteins and their complexes with target mRNAs in the aetiology of various dysfunctions, has suggested the great potential of compounds able to interfere with the complex stability as an innovative pharmacological strategy for the treatment of numerous diseases. Here, we present a rational follow-up investigation of the interaction between ELAV isoform HuR and structurally-related compounds (i.e., flavonoids and coumarins), naturally decorated with different functional groups, by means of STD-NMR and Molecular Modelling. Our results represent the foundation for the development of potent and selective ligands able to interfere with ELAV\u2013RNA complexes

Indirect signals from light neutralinos in supersymmetric models without gaugino mass unification

We examine indirect signals produced by neutralino self-annihilations, in the galactic halo or inside celestial bodies, in the frame of an effective MSSM model without gaugino-mass unification at a grand unification scale. We compare our theoretical predictions with current experimental data of gamma-rays and antiprotons in space and of upgoing muons at neutrino telescopes. Results are presented for a wide range of the neutralino mass, though our discussions are focused on light neutralinos. We find that only the antiproton signal is potentially able to set constraints on very low-mass neutralinos, below 20 GeV. The gamma-ray signal, both from the galactic center and from high galactic latitudes, requires significantly steep profiles or substantial clumpiness in order to reach detectable levels. The up-going muon signal is largely below experimental sensitivities for the neutrino flux coming from the Sun; for the flux from the Earth an improvement of about one order of magnitude in experimental sensitivities (with a low energy threshold) can make accessible neutralino masses close to O, Si and Mg nuclei masses, for which resonant capture is operative.Comment: 17 pages, 1 tables and 5 figures, typeset with ReVTeX4. The paper may also be found at http://www.to.infn.it/~fornengo/papers/indirect04.ps.gz or through http://www.astroparticle.to.infn.it/. Limit from BR(Bs--> mu+ mu-) adde

Hadronic contributions to (g−2)(g-2) of the leptons and to the effective fine structure constant α(MZ2)\alpha(M_Z^2)

The hadronic contributions to the anomalous magnetic moments of the leptons and to the effective fine structure constant at the Z-mass are reevaluated using all presently available $e^+ e^-$ data.Comment: 36 pages, 11 Postscript figures, available at ftp://129.129.40.58/pub/preprints/vapogm2.ps.g

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

High-energy astrophysics with neutrino telescopes

Neutrino astrophysics offers new perspectives on the Universe investigation: high energy neutrinos, produced by the most energetic phenomena in our Galaxy and in the Universe, carry complementary (if not exclusive) information about the cosmos with respect to photons. While the small interaction cross section of neutrinos allows them to come from the core of astrophysical objects, it is also a drawback, as their detection requires a large target mass. This is why it is convenient put huge cosmic neutrino detectors in natural locations, like deep underwater or under-ice sites. In order to supply for such extremely hostile environmental conditions, new frontiers technologies are under development. The aim of this work is to review the motivations for high energy neutrino astrophysics, the present status of experimental results and the technologies used in underwater/ice Cherenkov experiments, with a special focus on the efforts for the construction of a km3 scale detector in the Mediterranean Sea.Comment: 88 pages and 41 figure